Unknown

Dataset Information

A Practical Guide to Immunoassay Method Validation.


ABSTRACT: Biochemical markers have a central position in the diagnosis and management of patients in clinical medicine, and also in clinical research and drug development, also for brain disorders, such as Alzheimer's disease. The enzyme-linked immunosorbent assay (ELISA) is frequently used for measurement of low-abundance biomarkers. However, the quality of ELISA methods varies, which may introduce both systematic and random errors. This urges the need for more rigorous control of assay performance, regardless of its use in a research setting, in clinical routine, or drug development. The aim of a method validation is to present objective evidence that a method fulfills the requirements for its intended use. Although much has been published on which parameters to investigate in a method validation,

SUBMITTER: Andreasson U 

PROVIDER: S-EPMC4541289 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature